Ed Ebbers - 01 Jun 2021 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
EVP & GM, Dermatology
Signature
/s/ Sandra Gardiner, as Attorney-in-Fact
Issuer symbol
PLSE
Transactions as of
01 Jun 2021
Net transactions value
-$27,859
Form type
4
Filing time
03 Jun 2021, 17:37:09 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Tax liability $27,859 -1,485 -3.6% $18.76 39,300 01 Jun 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the total number of shares withheld by the Company to settle the Reporting Person's minimum tax liability pursuant to the contractual provisions of the June 2018 Restricted Stock Unit grant agreement previously disclosed.
F2 Includes shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan.